TIL
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
TIL
Sep 21, 2024, 15:21 |
Insight
Ulrike Harjes: Promising response rates with Nivolumab in TNBC patients
Ulrike Harjes, Senior Editor at Nature Medicine, posted the following on X: “Out now in Nature…
Jul 27, 2024, 10:03 |
Insight
Patrick Hwu: The exciting use of tumor-infiltrating lymphocyte therapy for sarcoma
Patrick Hwu shared on X: "In honor of Sarcoma Awareness Month, John E Mullinax, section…
Apr 7, 2024, 11:53 |
Insight
Roberto Leon-Ferre: The role of immune activation on the prognosis of early TNBC if chemo is not given?
Roberto Leon-Ferre, Assistant Professor at Mayo Clinic, shared on X/Twitter: "What is the role of…
Feb 23, 2024, 17:44 |
Drugs
Allison Betof Warner: The TIL team at Stanford Cancer Institute did our first surgical tumor harvest for AMTAGVI (lifileucel) this morning!
Allison Betof Warner, Director of Melanoma Medical Oncology and Solid Tumor Cellular Therapy at Stanford…
Feb 22, 2024, 23:27 |
Blog
Amalya Sargsyan: First approved T cell therapy for solid tumors
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared a post by Nicholas Restifo,…
All:
5
Posts:
1 - 100
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube